BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37858609)

  • 1. Estrogen-induced reactive oxygen species, through epigenetic reprogramming, causes increased growth in breast cancer cells.
    Roy P; Kandel R; Sawant N; Singh KP
    Mol Cell Endocrinol; 2024 Jan; 579():112092. PubMed ID: 37858609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA demethylation by 5-aza-2-deoxycytidine treatment abrogates 17 beta-estradiol-induced cell growth and restores expression of DNA repair genes in human breast cancer cells.
    Singh KP; Treas J; Tyagi T; Gao W
    Cancer Lett; 2012 Mar; 316(1):62-9. PubMed ID: 22082530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells.
    Mahalingaiah PK; Ponnusamy L; Singh KP
    Breast Cancer Res Treat; 2015 Aug; 153(1):41-56. PubMed ID: 26208486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
    Chang YW; Singh KP
    PLoS One; 2017; 12(3):e0174227. PubMed ID: 28323900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic exposure to arsenic and estrogen on epigenetic regulatory genes expression and epigenetic code in human prostate epithelial cells.
    Treas JN; Tyagi T; Singh KP
    PLoS One; 2012; 7(8):e43880. PubMed ID: 22952798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast epithelial and breast cancer cells.
    Messier TL; Boyd JR; Gordon JAR; Tye CE; Page NA; Toor RH; Zaidi SK; Komm BS; Frietze S; Stein JL; Lian JB; Stein GS
    PLoS One; 2022; 17(7):e0271725. PubMed ID: 35862394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Kar S; Patra SK
    Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor potentiates mTORC2 signaling in breast cancer cells by upregulating superoxide anions.
    Kumari Kanchan R; Tripathi C; Singh Baghel K; Kumar Dwivedi S; Kumar B; Sanyal S; Sharma S; Mitra K; Garg V; Singh K; Sultana S; Kamal Tripathi R; Kumar Rath S; Bhadauria S
    Free Radic Biol Med; 2012 Nov; 53(10):1929-41. PubMed ID: 23000059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer.
    Doherty LF; Bromer JG; Zhou Y; Aldad TS; Taylor HS
    Horm Cancer; 2010 Jun; 1(3):146-55. PubMed ID: 21761357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer.
    Tsuboi K; Kaneko Y; Nagatomo T; Fujii R; Hanamura T; Gohno T; Yamaguchi Y; Niwa T; Hayashi SI
    J Steroid Biochem Mol Biol; 2017 Mar; 167():115-125. PubMed ID: 27888136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic Modification.
    Su CH; Lin IH; Tzeng TY; Hsieh WT; Hsu MT
    PLoS One; 2016; 11(11):e0166090. PubMed ID: 27806114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous estrogens-breast cancer and chemoprevention.
    Starek-Świechowicz B; Budziszewska B; Starek A
    Pharmacol Rep; 2021 Dec; 73(6):1497-1512. PubMed ID: 34462889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells.
    Rodriguez BA; Weng YI; Liu TM; Zuo T; Hsu PY; Lin CH; Cheng AL; Cui H; Yan PS; Huang TH
    Carcinogenesis; 2011 Jun; 32(6):812-21. PubMed ID: 21304052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor alpha (ERα)-mediated coregulator binding and gene expression discriminates the toxic ERα agonist diethylstilbestrol (DES) from the endogenous ERα agonist 17β-estradiol (E2).
    Adam AHB; de Haan LHJ; Estruch IM; Hooiveld GJEJ; Louisse J; Rietjens IMCM
    Cell Biol Toxicol; 2020 Oct; 36(5):417-435. PubMed ID: 32088792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorinated chemicals, PFOS and PFOA, enhance the estrogenic effects of 17β-estradiol in T47D human breast cancer cells.
    Sonthithai P; Suriyo T; Thiantanawat A; Watcharasit P; Ruchirawat M; Satayavivad J
    J Appl Toxicol; 2016 Jun; 36(6):790-801. PubMed ID: 26234195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
    Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC
    Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct estradiol and diethylstilbestrol actions on early- versus late-stage prostate cancer cells.
    Koong LY; Watson CS
    Prostate; 2014 Dec; 74(16):1589-603. PubMed ID: 25213831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-induced DNA synthesis in vascular endothelial cells is mediated by ROS signaling.
    Felty Q
    BMC Cardiovasc Disord; 2006 Apr; 6():16. PubMed ID: 16608521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.